Immunic, inc. to announce financial results for the first quarter ended march 31, 2024, and provide corporate update

– webcast to be held at 8:00 am et on may 8, 2024 – new york , may 1, 2024 /prnewswire/ -- immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the company will release its financial results for the first quarter ended march 31, 2024, including a corporate update, on wednesday, may 8, 2024, before the opening of the u.s. financial markets. a webcast will follow at 8:00 am et.
IMUX Ratings Summary
IMUX Quant Ranking